Nancy K. Sweitzer, MD, PhD

Related Links

Research Profile

Education

• BA: University of Pennsylvania, Philadelphia, PA (1984)
• MD, PhD, Physiology: University of Wisconsin, Madison, WI (1993)
• Intern/Resident Internal Medicine : Brigham & Women’s Hospital, Boston, MA (1996)
• Fellowship, Cardiovascular Medicine: Brigham & Women’s Hospital, Boston, MA (1998)
• Fellowship, Heart Failure and Cardiac Transplant: Brigham & Women’s Hospital, Boston, MA (1999)
• Clinical Investigator Preparatory Program: University of Wisconsin, Madison, WI (2006)

Board Certifications

• Cardiovascular Disease
• National Board of Echocardiography
• Advanced Heart Failure and Transplant Cardiology

Recognition

• American Heart Association Heart Failure Science Advisory Group, 2019 – Present
• Co-Director, UAHS Clinical Translational Sciences Graduate Program, 2020 – Present
• NIH Foundation HFpEF Accelerating Medicine Partnership Steering Committee Member, 2020 – Present
• Chair, NIH/NHLBI Clinical Trials Review Committee (CLTR), 2021-2022
• 2021 Dr. Nancy C. Flowers and Dr. Leo G. Horan Lectureship in Cardiology, University of Kentucky, November 2021
• ACC Honorary Speaker, Kanu and Docey Chatterjee Keynote address, May 2021
• Steering committee of the NIH-sponsored TOPCAT trial, “Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist” 2009 – present  Steering committee of the echo-vascular substudy of the NIH-sponsored TOPCAT trial, “Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist”. 2009-present
• Member of American Heart Association Cardiac Biology Review Committee 2012-2014
• Chair, Data Safety Monitoring Board, Array ARRAY-797-231 A Pilot Study to Investigate the Efficacy and Safety of ARRY-371797 in Patients with Symptomatic Familial Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation 2013-2016
• Editor in Chief, Circulation: Heart Failure 2017- Present
• AHA Research Leadership Academy Faculty, 2016 – Present
• US Country Leader for VICTORIA Trial, sponsored by Merck 2015 – Present
• Faculty, Eureka Institute for Translational Medicine, Aretusa, Siracusa, Italy. 2016 – Present
• Member, NHLBI Clinical Trials Review Committee (CLTR) 2017 – 2021
• Miriam Lemberg Professorship in Cardiovascular Disease Lecture, University of Miami March 20, 2019
• Thomas W Smith MD Memorial Lecture, Brigham and Women’s Hospital April 28, 2019 – Heart Failure with Preserved Ejection Fraction, 2019
• Keynote Lecturer, Medical College of Wisconsin’s Cardiovascular Center Retreat, October 2019
• 45th Annual Meeting of the Egyptian Society of Cardiology, Cairo, Egypt, February 2018, 3 invited presentations, 2018
• HFSA Future Leaders in Heart Failure Symposium, Faculty May 2018
• Mentoring Award, University of Arizona College of Medicine, 2018
• Keynote Speaker, 4th Annual Tucson Local Media Influential Health and Medical Awards
• Keynote Speaker, University of Alabama Comprehensive Cardiovascular Center 7th Annual Focus on Heart Failure, September 6, 2018
• 2018 Maurice Sokolow Memorial Lecture in Cardiology, UCSF, October 3, 2018
• Keynote Speaker, Alpha Phi Red Dress Gala, Tucson, AZ, October 5, 2018
• Keynote Speaker, University of Washington 5th Annual Heart Failure Symposium, Full Spectrum of Heart Failure: Optimizing Outcomes, October 19, 2018
• Best Lecturer award recipient from the UA CV Medicine Fellows in 2016 and 2017
• Fellow, Heart Failure Society of America, 2017

Clinical Interests

Heart failure and cardiomyopathies, heart failure with preserved ejection fraction, advanced heart failure, cardiogenic shock, mechanical circulatory support and heart transplantation.

Research Interests

Dr. Sweitzer’s research interest include human studies of all aspects of heart failure, including cardiovascular clinical trials, , novel therapeutics in heart failure, heart failure with preserved ejection fraction, improving quality of cardiovascular care, improving disparities in cardiovascular care, cognitive dysfunction in cardiovascular diseases.